Jan Borén
Jan Borén
Verified email at
Cited by
Cited by
2016 ESC/EAS guidelines for the management of dyslipidaemias
AL Catapano, I Graham, G De Backer, O Wiklund, MJ Chapman, H Drexel, ...
Polish Heart Journal (Kardiologia Polska) 74 (11), 1234-1318, 2016
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European …
BA Ference, HN Ginsberg, I Graham, KK Ray, CJ Packard, E Bruckert, ...
European heart journal 38 (32), 2459-2472, 2017
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of …
BG Nordestgaard, MJ Chapman, SE Humphries, HN Ginsberg, L Masana, ...
European heart journal 34 (45), 3478-3490, 2013
Lipoprotein (a) as a cardiovascular risk factor: current status
BG Nordestgaard, MJ Chapman, K Ray, J Borén, F Andreotti, GF Watts, ...
European heart journal 31 (23), 2844-2853, 2010
Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications
I Tabas, KJ Williams, J Borén
Circulation 116 (16), 1832-1844, 2007
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
MJ Chapman, HN Ginsberg, P Amarenco, F Andreotti, J Borén, ...
European heart journal 32 (11), 1345-1361, 2011
Subendothelial retention of atherogenic lipoproteins in early atherosclerosis
K Skålén, M Gustafsson, EK Rydberg, LM Hultén, O Wiklund, TL Innerarity, ...
Nature 417 (6890), 750-754, 2002
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on …
M Cuchel, E Bruckert, HN Ginsberg, FJ Raal, RD Santos, RA Hegele, ...
European heart journal 35 (32), 2146-2157, 2014
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European …
J Boren, MJ Chapman, RM Krauss, CJ Packard, JF Bentzon, CJ Binder, ...
European heart journal 41 (24), 2313-2330, 2020
Overproduction of very low–density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome
M Adiels, SO Olofsson, MR Taskinen, J Borén
Arteriosclerosis, thrombosis, and vascular biology 28 (7), 1225-1236, 2008
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
A Wiegman, SS Gidding, GF Watts, MJ Chapman, HN Ginsberg, M Cuchel, ...
European heart journal 36 (36), 2425-2437, 2015
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint …
BG Nordestgaard, A Langsted, S Mora, G Kolovou, H Baum, E Bruckert, ...
European heart journal 37 (25), 1944-1958, 2016
Overproduction of large VLDL particles is driven by increased liver fat content in man
M Adiels, MR Taskinen, C Packard, MJ Caslake, A Soro-Paavonen, ...
Diabetologia 49, 755-765, 2006
The gut microbiota modulates host energy and lipid metabolism in mice [S]
VR Velagapudi, R Hezaveh, CS Reigstad, P Gopalacharyulu, L Yetukuri, ...
Journal of lipid research 51 (5), 1101-1112, 2010
The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent
RM Mancina, P Dongiovanni, S Petta, P Pingitore, M Meroni, R Rametta, ...
Gastroenterology 150 (5), 1219-1230. e6, 2016
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
RA Hegele, HN Ginsberg, MJ Chapman, BG Nordestgaard, ...
The lancet Diabetes & endocrinology 2 (8), 655-666, 2014
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
P Dongiovanni, S Petta, C Maglio, AL Fracanzani, R Pipitone, E Mozzi, ...
Hepatology 61 (2), 506-514, 2015
Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease
H Gylling, J Plat, S Turley, HN Ginsberg, L Ellegård, W Jessup, PJ Jones, ...
Atherosclerosis 232 (2), 346-360, 2014
New insights into the pathophysiology of dyslipidemia in type 2 diabetes
MR Taskinen, J Borén
Atherosclerosis 239 (2), 483-495, 2015
The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity
J Borén, KJ Williams
Current opinion in lipidology 27 (5), 473-483, 2016
The system can't perform the operation now. Try again later.
Articles 1–20